Vonoprazan-associated Clostridioides difficile infection: an analysis of the Japanese Adverse Drug Event Report and the FDA Adverse Event Reporting System.
Mengling OuyangShupeng ZouQian ChengXuan ShiYazheng ZhaoMinghui SunPublished in: Therapeutic advances in drug safety (2024)
While signal detection analysis based on the JADER and FAERS databases could not establish causality, our study demonstrated that both vonoprazan and PPIs were significantly associated with CDI. Vonoprazan showed a stronger association with CDI in both databases.